| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/06/2005 | US20050002964 Adhesion inhibition of fungi |
| 01/06/2005 | US20050002955 Acquired Immune Deficiency Syndrome (AIDS) diagnosis and treatment |
| 01/06/2005 | US20050002954 Peptide-based vaccine for influenza |
| 01/06/2005 | US20050002952 Proteinaceous antigen with 3-beta-(N-(N'-N'-dimethylaminoethane)carbamoyl)cholesterol; increasing immunogenicity |
| 01/06/2005 | US20050002950 Vaccine preventing infection |
| 01/06/2005 | US20050002944 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 01/06/2005 | US20050002943 Amp-kinase agonists or adenosine pro-drugs as immuno-stimulating agents |
| 01/06/2005 | US20050002901 Compositions and methods for treating coronavirus infection and SARS |
| 01/06/2005 | CA2530662A1 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 01/06/2005 | CA2530434A1 Immunization method against neisseria meningitidis serogroups a and c |
| 01/06/2005 | CA2530063A1 Compositions of lipopeptide antibiotic derivatives and methods of use thereof |
| 01/06/2005 | CA2528067A1 Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli |
| 01/06/2005 | CA2527708A1 Crystalline forms of valacyclovir hydrochloride |
| 01/06/2005 | CA2526343A1 Ancestral viruses and vaccines |
| 01/06/2005 | CA2526150A1 Treatment of humans with colloidal silver composition |
| 01/06/2005 | CA2526122A1 Compositions for down-regulation of ccr5 expression and methods of use therefor |
| 01/05/2005 | EP1493751A1 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
| 01/05/2005 | EP1493750A2 HCV regulated proteins |
| 01/05/2005 | EP1493743A1 Substituted bipiperidine intermediates and derivatives thereof |
| 01/05/2005 | EP1493034A2 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1 immunoreactivity |
| 01/05/2005 | EP1492876A1 Cationic amphiphiles for intracellular delivery of therapeutic molecules, composition, process and use thereof |
| 01/05/2005 | EP1492868A2 Method of modulating inflammatory response |
| 01/05/2005 | EP1492813A2 Ox40r binding agents |
| 01/05/2005 | EP1492798A1 N-(3-rifamycinyl)-carbamates, method of preparing them and their use for treating and preventing tuberculosis |
| 01/05/2005 | EP1492795A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 01/05/2005 | EP1492789A1 Tropane derivatives as ccr5 modulators |
| 01/05/2005 | EP1492785A1 New compounds |
| 01/05/2005 | EP1492783A1 4,5,6,7-tretrahydrobenzo(b) thiophene derivatives and methods for medical intervention against mycrobacterial infections |
| 01/05/2005 | EP1492780A1 5-substituted 1,1-dioxo-[1,2,5]thiazolidine-3-one derivatives as ptpase 1b inhibitors |
| 01/05/2005 | EP1492779A1 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity |
| 01/05/2005 | EP1492777A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidase inhibitors |
| 01/05/2005 | EP1492774A2 Pyrimidone derivatives useful for the treatment of inflammation and immunological diseases |
| 01/05/2005 | EP1492771A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 01/05/2005 | EP1492766A1 Improved cc-1065 analog synthesis |
| 01/05/2005 | EP1492756A1 Novel thyroid receptor ligands |
| 01/05/2005 | EP1492571A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 01/05/2005 | EP1492564A2 Amp-kinase agonists or adenosine pro-drugs as immuno-stimulating agents |
| 01/05/2005 | EP1492563A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/05/2005 | EP1492562A2 Virus-like particles of human papillomavirus |
| 01/05/2005 | EP1492555A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell population |
| 01/05/2005 | EP1492551A2 Ophthalmic, pharmaceutical and other healthcare preparations with naturally occuring plant compounds, extracts and derivatives |
| 01/05/2005 | EP1492546A1 Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system |
| 01/05/2005 | EP1492545A1 Agents for treating i flaviviridae /i infections |
| 01/05/2005 | EP1492542A1 Hormone replacement therapy |
| 01/05/2005 | EP1492533A1 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis |
| 01/05/2005 | EP1492531A2 Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin |
| 01/05/2005 | EP1492530A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors |
| 01/05/2005 | EP1492529A1 Oral administration of epothilones |
| 01/05/2005 | EP1492522A1 Ansamycin formulations and methods for producing and using same |
| 01/05/2005 | EP1492518A2 Tuberculosis treatment using pleuromutilin derivatives |
| 01/05/2005 | EP1492512A1 Method for systemic drug delivery through the nail |
| 01/05/2005 | EP1492510A1 Low dose liquid entecavir formulations and use |
| 01/05/2005 | EP1442038A4 Crystalline forms of carbapenem antibiotics and methods of preparation |
| 01/05/2005 | EP1282414B1 Felbamate derived compounds for treating neuropathic pain |
| 01/05/2005 | EP1226126B1 Pyrimidine derivatives |
| 01/05/2005 | EP1200580B1 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 01/05/2005 | EP1027349B1 Tetrahydrofuran phosphate- and hydroxy esters, as prodrugs for the corresponding antifungal agent |
| 01/05/2005 | DE19957065B4 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 01/05/2005 | CN1561389A Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 01/05/2005 | CN1561387A Probiotic bifidobacterium strains |
| 01/05/2005 | CN1561343A Soluble T cell receptor |
| 01/05/2005 | CN1561342A Novel macrolide derivative having effect of potentiating anti-fungus activity |
| 01/05/2005 | CN1561332A Preparation of HIV protease inhibitors |
| 01/05/2005 | CN1561232A Therapeutic agent comprising a B-subunit of a protein toxin |
| 01/05/2005 | CN1561230A Antigenic compositions |
| 01/05/2005 | CN1561229A Virus coat protein/receptor chimeras and methods of use |
| 01/05/2005 | CN1561227A Method for treating hepatitis C virus infection in treatment failure patients |
| 01/05/2005 | CN1561224A A method of reducing mortality and morbidity associated with critical illnesses |
| 01/05/2005 | CN1561221A Novel medicinal herbal composition for treating liver diseases and HIV |
| 01/05/2005 | CN1561220A Method for the treatment of inflammation |
| 01/05/2005 | CN1561218A Enteral compositions for the prevention and/or treatment of sepsis |
| 01/05/2005 | CN1561216A Novel compounds |
| 01/05/2005 | CN1561215A Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid compounds used as nmda antagonist |
| 01/05/2005 | CN1561208A Methods to mobilize progenitor/stem cells |
| 01/05/2005 | CN1561207A Therapeutic delivery of carbon monoxide |
| 01/05/2005 | CN1561204A Use of COX-2 inhibitors for preventing immunodeficiency |
| 01/05/2005 | CN1561202A Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same |
| 01/05/2005 | CN1561201A Pharmaceutical compositions comprising colloidal silicon dioxide |
| 01/05/2005 | CN1561200A Flashmelt oral dosage formulation |
| 01/05/2005 | CN1561199A Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 01/05/2005 | CN1561164A 抗微生物剂 Antimicrobial agent |
| 01/05/2005 | CN1560265A Preparation process of burduck protoglucoside of anti virus and antiptmour natural medicine |
| 01/05/2005 | CN1560258A Preparation process of antibacterial peptide |
| 01/05/2005 | CN1560253A Preparation of antibiotic hPAB with multicopy tandem peptide |
| 01/05/2005 | CN1560249A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 01/05/2005 | CN1560074A Polypeptide of inhibiting crown virus and its derivant |
| 01/05/2005 | CN1560064A Derivative of vibothymidine and its preparation process and application |
| 01/05/2005 | CN1560059A Synthesis process for Adefovir ester of anti hepatitis type B virus medicine |
| 01/05/2005 | CN1560051A 取代吡唑化合物 A substituted pyrazole compound |
| 01/05/2005 | CN1560035A 5-hydroxylic indole-3-carboxylic ester kind derivantion |
| 01/05/2005 | CN1559611A Preparation of horse family animal anti human, pultry grippe immune globulin and its medicinal preparation |
| 01/05/2005 | CN1559610A Vaccine curing for disease and its preparation method |
| 01/05/2005 | CN1559593A Chinese medicinal incense used for preventing infectious disease and its making method |
| 01/05/2005 | CN1559579A Preparation of medicine for treating herpes simplex keratitis |
| 01/05/2005 | CN1559572A Compound Sanhuang powder |
| 01/05/2005 | CN1559560A Chinese medicinal preparation for treating skin mycosis and its prepration method |
| 01/05/2005 | CN1559552A Broad-pectrum sterilization suppository |
| 01/05/2005 | CN1559532A Chinese medicinal mixture for treating viral hepatitis |
| 01/05/2005 | CN1559530A Ointment preparation for prevemting common cold |
| 01/05/2005 | CN1559522A Houttuynia injection and its processing technology |